Telesta Therapeutics Inc  

(Public, TSE:TST)   Watch this stock  
Find more results for TSE:bnc
+0.025 (5.43%)
Aug 28 - Close
TSE data delayed by 15 mins - Disclaimer
Currency in CAD
Range 0.46 - 0.54
52 week 0.20 - 0.54
Open 0.46
Vol / Avg. 4.21M/336,969.00
Mkt cap 136.19M
P/E     -
Div/yield     -
EPS -0.07
Shares 280.80M
Beta 0.21
Inst. own     -

Key stats and ratios

Q1 (Mar '15) 2014
Net profit margin - -22818.92%
Operating margin - -20463.78%
EBITD margin - -10189.19%
Return on average assets -43.24% -88.91%
Return on average equity - -
Employees 53 -
CDP Score - -


231 Dundas Street East
+1-613-9668058 (Phone)
+1-613-9664177 (Fax)

Website links


Telesta Therapeutics Inc., formerly Bioniche Life Sciences Inc. is a Canada-based company engaged in human therapeutics. Its Health business, which include the Econichetechnology and the Vaccine Manufacturing Centre (VMC). The VMC was purpose-built to make the E. coli O157 vaccine but could be modified to make other products.

Officers and directors

James M. Rae Independent Chairman of the Board
Michael Joseph Berendt Ph.D. Chief Executive Officer, Chief Scientific Officer
Age: 66
Brian R. Ford Chief Financial Officer
Age: 65
Donald Olds Chief Operating Officer
Mohamed Elrafih Vice President - Manufacturing Operations
Yvon Bastien Independent Director
Age: 66
Roderick Edward Budd CPA Independent Director
Age: 63
Lyne Fortin Independent Director
Gregory David Gubitz Independent Director